
BIONIKK: Results of the first randomized clinical trial based on molecular groups in metastatic renal cell carcinoma
Kidney cancer represents 3% of all diagnosed cancers. In France, more than 11,000 new cases were reported in 2011, including 30% of patients with metastases. From a histological point of
